190 related articles for article (PubMed ID: 35778954)
1. LncRNA LIFR-AS1 overexpression suppressed the progression of serous ovarian carcinoma.
Liu F; Cao L; Zhang Y; Xia X; Ji Y
J Clin Lab Anal; 2022 Aug; 36(8):e25470. PubMed ID: 35778954
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA LIFR-AS1 suppressed the proliferation, angiogenesis, migration and invasion of papillary thyroid cancer cells via the miR-31-5p/SIDT2 axis.
Yi D; Zhang D; He J
Cell Cycle; 2021 Dec; 20(24):2619-2637. PubMed ID: 34781815
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA LIFR-AS1 suppresses proliferation, migration and invasion and promotes apoptosis through modulating miR-4262/NF-κB pathway in glioma.
Ding H; Cui L; Wang C
Neurol Res; 2021 Mar; 43(3):210-219. PubMed ID: 33070767
[TBL] [Abstract][Full Text] [Related]
4. KCNMA1-AS1 attenuates apoptosis of epithelial ovarian cancer cells and serves as a risk factor for poor prognosis of epithelial ovarian cancer.
Ma SY; Wei P; Qu F
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4629-4641. PubMed ID: 31210304
[TBL] [Abstract][Full Text] [Related]
5. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
Wang D; Zheng Y
Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide screening for differentially methylated long noncoding RNAs identifies LIFR-AS1 as an epigenetically regulated lncRNA that inhibits the progression of colorectal cancer.
Song P; Li Y; Wang F; Pu L; Bao L; Gao H; Zhu C; Wang M; Tao L
Clin Epigenetics; 2022 Oct; 14(1):138. PubMed ID: 36316703
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA HAL suppresses the migration and invasion of serous ovarian cancer by inhibiting EMT signaling pathway.
Wu K; Li L; Li L; Wang D
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32039453
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis.
Yan H; Li H; Li P; Li X; Lin J; Zhu L; Silva MA; Wang X; Wang P; Zhang Z
J Exp Clin Cancer Res; 2018 Sep; 37(1):237. PubMed ID: 30249278
[TBL] [Abstract][Full Text] [Related]
9. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
Zhang Y; Dun Y; Zhou S; Huang XH
Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
[TBL] [Abstract][Full Text] [Related]
10. Silencing of SBF2-AS1 inhibits cell growth and invasion by sponging microRNA-338-3p in serous ovarian carcinoma.
Luan AA; Hou LL; Zhang FY
Kaohsiung J Med Sci; 2022 Apr; 38(4):302-311. PubMed ID: 34850542
[TBL] [Abstract][Full Text] [Related]
11. LIFR-AS1 modulates Sufu to inhibit cell proliferation and migration by miR-197-3p in breast cancer.
Xu F; Li H; Hu C
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31127025
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of long noncoding RNA SLC26A4-AS1 inhibits the epithelial-mesenchymal transition via the MAPK pathway in papillary thyroid carcinoma.
Wang DP; Tang XZ; Liang QK; Zeng XJ; Yang JB; Xu J
J Cell Physiol; 2020 Mar; 235(3):2403-2413. PubMed ID: 31556116
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SSTR5-AS1 as a Prognostic Marker Promotes Cell Proliferation and Epithelial-to-Mesenchymal Transition in Prostate Cancer.
Yuan S; Bi J; Zhang Y
Crit Rev Eukaryot Gene Expr; 2023; 33(2):1-12. PubMed ID: 36734853
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis.
Sun Z; Gao S; Xuan L; Liu X
J Cell Mol Med; 2020 Apr; 24(7):4275-4285. PubMed ID: 32135030
[TBL] [Abstract][Full Text] [Related]
15. M
Chen JQ; Tao YP; Hong YG; Li HF; Huang ZP; Xu XF; Zheng H; Hu LK
Cell Cycle; 2021 Dec; 20(23):2507-2518. PubMed ID: 34658294
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of long noncoding RNA DLX6-AS1 defines good prognosis and inhibits proliferation and metastasis in human epithelial ovarian cancer cells via Notch signaling pathway.
Zhao J; Liu HR
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3243-3252. PubMed ID: 31081076
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
Xu C; Cui H; Li H; Wu Y; An H; Guo C
J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
[TBL] [Abstract][Full Text] [Related]
18. The lncRNA TP73-AS1 promotes ovarian cancer cell proliferation and metastasis via modulation of MMP2 and MMP9.
Wang X; Yang B; She Y; Ye Y
J Cell Biochem; 2018 Sep; 119(9):7790-7799. PubMed ID: 29904939
[TBL] [Abstract][Full Text] [Related]
19. lncRNA MIAT Regulates Cell Growth, Migration, and Invasion Through Sponging miR-150-5p in Ovarian Cancer.
Zhou S; Xu A; Song T; Gao F; Sun H; Kong X
Cancer Biother Radiopharm; 2020 Nov; 35(9):650-660. PubMed ID: 32186927
[No Abstract] [Full Text] [Related]
20. Clinical significance of lncRNA FAM83H-AS1 in ovarian cancer.
Gong YB; Zou YF
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4656-4662. PubMed ID: 31210291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]